Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia

Sung-Gu Kang, Bum Sik Tae, Sam Hong Min, Young Hwii Ko, Seok Ho Kang, Jeong Gu Lee, Je-Jong Kim, Jun Cheon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sedation may result in reduction in pain during transrectal ultrasound (TRUS)-guided prostate biopsies. We aimed to evaluate the efficacy and safety of a combination of propofol and remifentanil infusion during TRUS-guided prostate biopsy and the related increases in health care costs. From January to September 2010, 100 men undergoing a transrectal prostate biopsy were randomized into two groups. In Group 1, 50 patients received a combined infusion of propofol and remifentanil; in Group 2, 50 patients received lidocaine jelly. After TRUS-guided biopsies were performed, pain and patient satisfaction were evaluated by a 10-point visual analog scale (VAS), and a cost-related patient satisfaction questionnaire was completed by all patients. Patients were also asked whether they would be willing to undergo repeat biopsy by the same method. Patients in Group 1 showed a significantly lower VAS score than those in Group 2 (mean VAS score: 0.9±1.1 versus 6.3±2.5; P<0.001). In addition, the patient satisfaction scale was significantly higher in Group 1 (P=0.002). Although the overall cost was significantly higher in Group 1 (P=0.006), patient satisfaction scales considering cost were also higher in this group (P=0.009). A combination of propofol and remifentanil is a safe and effective way to decrease patient pain and increase patient satisfaction during TRUS-guided prostate biopsy. Although the costs were higher in the group that received sedation, as expected, the patients exhibited heightened satisfaction and willingness to repeat biopsies by the same method.

Original languageEnglish
Pages (from-to)724-727
Number of pages4
JournalAsian Journal of Andrology
Volume13
Issue number5
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

Prostate
Anesthesia
Patient Satisfaction
Biopsy
Costs and Cost Analysis
Propofol
Visual Analog Scale
Pain
Lidocaine
Health Care Costs
Safety
remifentanil

Keywords

  • biopsy
  • pain
  • prostate
  • sedation

ASJC Scopus subject areas

  • Urology

Cite this

Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia. / Kang, Sung-Gu; Tae, Bum Sik; Min, Sam Hong; Ko, Young Hwii; Kang, Seok Ho; Lee, Jeong Gu; Kim, Je-Jong; Cheon, Jun.

In: Asian Journal of Andrology, Vol. 13, No. 5, 01.09.2011, p. 724-727.

Research output: Contribution to journalArticle

@article{389756a779204fc58fac8dbcbf355cf4,
title = "Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia",
abstract = "Sedation may result in reduction in pain during transrectal ultrasound (TRUS)-guided prostate biopsies. We aimed to evaluate the efficacy and safety of a combination of propofol and remifentanil infusion during TRUS-guided prostate biopsy and the related increases in health care costs. From January to September 2010, 100 men undergoing a transrectal prostate biopsy were randomized into two groups. In Group 1, 50 patients received a combined infusion of propofol and remifentanil; in Group 2, 50 patients received lidocaine jelly. After TRUS-guided biopsies were performed, pain and patient satisfaction were evaluated by a 10-point visual analog scale (VAS), and a cost-related patient satisfaction questionnaire was completed by all patients. Patients were also asked whether they would be willing to undergo repeat biopsy by the same method. Patients in Group 1 showed a significantly lower VAS score than those in Group 2 (mean VAS score: 0.9±1.1 versus 6.3±2.5; P<0.001). In addition, the patient satisfaction scale was significantly higher in Group 1 (P=0.002). Although the overall cost was significantly higher in Group 1 (P=0.006), patient satisfaction scales considering cost were also higher in this group (P=0.009). A combination of propofol and remifentanil is a safe and effective way to decrease patient pain and increase patient satisfaction during TRUS-guided prostate biopsy. Although the costs were higher in the group that received sedation, as expected, the patients exhibited heightened satisfaction and willingness to repeat biopsies by the same method.",
keywords = "biopsy, pain, prostate, sedation",
author = "Sung-Gu Kang and Tae, {Bum Sik} and Min, {Sam Hong} and Ko, {Young Hwii} and Kang, {Seok Ho} and Lee, {Jeong Gu} and Je-Jong Kim and Jun Cheon",
year = "2011",
month = "9",
day = "1",
doi = "10.1038/aja.2011.16",
language = "English",
volume = "13",
pages = "724--727",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia

AU - Kang, Sung-Gu

AU - Tae, Bum Sik

AU - Min, Sam Hong

AU - Ko, Young Hwii

AU - Kang, Seok Ho

AU - Lee, Jeong Gu

AU - Kim, Je-Jong

AU - Cheon, Jun

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Sedation may result in reduction in pain during transrectal ultrasound (TRUS)-guided prostate biopsies. We aimed to evaluate the efficacy and safety of a combination of propofol and remifentanil infusion during TRUS-guided prostate biopsy and the related increases in health care costs. From January to September 2010, 100 men undergoing a transrectal prostate biopsy were randomized into two groups. In Group 1, 50 patients received a combined infusion of propofol and remifentanil; in Group 2, 50 patients received lidocaine jelly. After TRUS-guided biopsies were performed, pain and patient satisfaction were evaluated by a 10-point visual analog scale (VAS), and a cost-related patient satisfaction questionnaire was completed by all patients. Patients were also asked whether they would be willing to undergo repeat biopsy by the same method. Patients in Group 1 showed a significantly lower VAS score than those in Group 2 (mean VAS score: 0.9±1.1 versus 6.3±2.5; P<0.001). In addition, the patient satisfaction scale was significantly higher in Group 1 (P=0.002). Although the overall cost was significantly higher in Group 1 (P=0.006), patient satisfaction scales considering cost were also higher in this group (P=0.009). A combination of propofol and remifentanil is a safe and effective way to decrease patient pain and increase patient satisfaction during TRUS-guided prostate biopsy. Although the costs were higher in the group that received sedation, as expected, the patients exhibited heightened satisfaction and willingness to repeat biopsies by the same method.

AB - Sedation may result in reduction in pain during transrectal ultrasound (TRUS)-guided prostate biopsies. We aimed to evaluate the efficacy and safety of a combination of propofol and remifentanil infusion during TRUS-guided prostate biopsy and the related increases in health care costs. From January to September 2010, 100 men undergoing a transrectal prostate biopsy were randomized into two groups. In Group 1, 50 patients received a combined infusion of propofol and remifentanil; in Group 2, 50 patients received lidocaine jelly. After TRUS-guided biopsies were performed, pain and patient satisfaction were evaluated by a 10-point visual analog scale (VAS), and a cost-related patient satisfaction questionnaire was completed by all patients. Patients were also asked whether they would be willing to undergo repeat biopsy by the same method. Patients in Group 1 showed a significantly lower VAS score than those in Group 2 (mean VAS score: 0.9±1.1 versus 6.3±2.5; P<0.001). In addition, the patient satisfaction scale was significantly higher in Group 1 (P=0.002). Although the overall cost was significantly higher in Group 1 (P=0.006), patient satisfaction scales considering cost were also higher in this group (P=0.009). A combination of propofol and remifentanil is a safe and effective way to decrease patient pain and increase patient satisfaction during TRUS-guided prostate biopsy. Although the costs were higher in the group that received sedation, as expected, the patients exhibited heightened satisfaction and willingness to repeat biopsies by the same method.

KW - biopsy

KW - pain

KW - prostate

KW - sedation

UR - http://www.scopus.com/inward/record.url?scp=80052464361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052464361&partnerID=8YFLogxK

U2 - 10.1038/aja.2011.16

DO - 10.1038/aja.2011.16

M3 - Article

VL - 13

SP - 724

EP - 727

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 5

ER -